Clinical Trials Browser

Phase 2 × Has results × Urothelial Cancer × Clear all

NCT02365597 2026-03-19

An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer

Phase 2 Active not recruiting

239 enrolled 32 charts 1 FDA

Urothelial Cancer

NCT02033993 2023-08-22

Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.

Phase 2 Completed

199 enrolled 14 charts

Urothelial Cancer

NCT00821327 2016-10-25

Gemzar, Cisp, Sunitinib Urothelial Ca

Phase 2 Completed

36 enrolled 9 charts

Urothelial Cancer